Top

Published in:

01-06-2018 | The Global Epidemic (SH Vermund, Section Editor)

Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics

Authors: Samuel R. Friedman, Leslie Williams, April M. Young, Jennifer Teubl, Dimitrios Paraskevis, Evangelia Kostaki, Carl Latkin, Danielle German, Pedro Mateu-Gelabert, Honoria Guarino, Tetyana I. Vasylyeva, Britt Skaathun, John Schneider, Ania Korobchuk, Pavlo Smyrnov, Georgios Nikolopoulos

Published in: Current HIV/AIDS Reports | Issue 3/2018

Abstract

Purpose

This paper presents an overview of different kinds of risk and social network methods and the kinds of research questions each can address.

Recent Findings

It also reviews what network research has discovered about how network characteristics are associated with HIV and other infections, risk behaviors, preventive behaviors, and care, and discusses some ways in which network-based public health interventions have been conducted.

Summary

Based on this, risk and social network research and interventions seem both feasible and valuable for addressing the many public health and social problems raised by the widespread use of opioids in the US South.

A Seidman k-core is defined as a set of members of the network (plus their links) such that every member of the k-core is linked by k or more links to another k-core member. Any given connected component can have only one 2-core, but many 3-cores or 4-cores. A 3-core will have to be a part of a 2-core, a 4-core will have to be part of a 3-core, and so forth. There are many measures that have been developed to measure the properties of social networks. Any edition of Wasserman, Stanley, and Faust, Katherine, Social Network Analysis: Methods and Applications (Structural Analysis in the Social Sciences), (First Edition 1994) Cambridge University Press, Cambridge, UK, West 20th St., New York, USA, Melbourne, Madrid, ISBN 978-0521387071 is a good reference for such measures.

Valente TW. Social networks and health: Models, methods, and applications: Oxford University Press; 2010.

Friedman SR, Bolyard M, Maslow C, Mateu-Gelabert P, Sandoval M. Harnessing the power of social networks to reduce HIV risk. Focus. 2005;20(1):5–6.PubMed

Friedman SR, Sandoval M, Mateu-Gelabert P, Rossi D, Gwadz M, Dombrowski K, et al. Theory, measurement and hard times: some issues for HIV/AIDS research. AIDS Behav. 2013;17(6):1915–25. https://doi.org/10.1007/s10461-013-0475-3.CrossRefPubMedPubMedCentral

Young AM, Rudolph AE, Su AE, King L, Jent S, Havens JR. Accuracy of name and age data provided about network members in a social network study of people who use drugs: implications for constructing sociometric networks. Ann Epidemiol. 2016;26(11):802–9.CrossRefPubMedPubMedCentral

Rudolph AE, Young AM, Havens JR. A rural/urban comparison of privacy and confidentiality concerns associated with providing sensitive location information in epidemiologic research involving persons who use drugs. Addict Behav. 2017;74:106–11.CrossRefPubMed

Wylie JL, Jolly A. Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada. Sex Transm Dis. 2001;28:14–24.CrossRefPubMed

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, et al. The global spread of HIV-1 subtype B epidemic. Infect Genet Evol. 2016;46:169–79.CrossRefPubMedPubMedCentral

Angelis K, Albert J, Mamais I, Magiorkinis G, Hatzakis A, Hamouda O, et al. Global dispersal pattern of HIV type 1 subtype CRF01_AE: a genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia. J Infect Dis. 2015;211(11):1735–44. https://doi.org/10.1093/infdis/jiu666.CrossRefPubMed

Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP, et al. Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology. 2013;57(3):908–16.CrossRefPubMed

10.

German D, Grabowski MK, Beyrer C. Enhanced use of phylogenetic data to inform public health approaches to HIV among men who have sex with men. Sex Health. 2016; https://doi.org/10.1071/SH16056.

11.

Hurt CB, Dennis AM. Putting it all together: lessons from the Jackson HIV outbreak investigation. Sex Transm Dis. 2013;40:213–5. https://doi.org/10.1097/OLQ.0b013e318284e3d2.CrossRefPubMed

12.

Vasylyeva TI, Friedman SR, Paraskevis D, Magiorkinis G. Integrating molecular epidemiology and social network analysis to study infectious diseases: towards a socio-molecular era for public health. Infect Genet Evol. 2016;46:248–55.CrossRefPubMedPubMedCentral

13.

Nikolopoulos GK, Pavlitina E, Muth SQ, Schneider J, Psichogiou M, Williams LD, et al. A network intervention that locates and intervenes with recently HIV-infected persons: the Transmission Reduction Intervention Project (TRIP). Sci Rep. 2016;6:38100. https://doi.org/10.1038/srep38100.NIHMSID837702.CrossRefPubMedPubMedCentral

14.

Friedman SR, Downing MJ, Smyrnov P, Nikolopoulos G, Schneider JA, Livak B, et al. Socially-integrated transdisciplinary HIV prevention. AIDS Behav. 2013;18(10)

15.

Skaathun B. Social network optimization for HIV preventive care. Dissertation, University of Chicago, 2016.

16.

Friedman SR, Flom PL, Kottiri BJ, Neaigus A, Sandoval M, Curtis R, et al. Consistent condom use in the heterosexual relationships of young adults who live in a high-HIV-risk neighborhood and do not use “hard drugs”. AIDS Care. 2001;13:285–96.CrossRefPubMed

17.

Friedman SR, Flom PL, Kottiri BJ, Neaigus A, Sandoval M, Fuld J, et al. Consistent condom use among drug-using youth in a high-HIV-risk neighborhood. AIDS Care. 2002;14:493–507.CrossRefPubMed

18.

Friedman SR, Jose B, Neaigus A, Goldstein M, Curtis R, Ildefonso G, et al. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS. 1994;8:357–61.CrossRefPubMed

19.

Neaigus A, Friedman SR, Jose B, Goldstein M, Curtis R, Ildefonso G, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr. 1996;11:499–509.CrossRef

20.

Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. 1999. Social networks, drug injectors’ lives, and HIV/AIDS New York: Kluwer/Plenum.

21.

Friedman SR, Neaigus A, Jose B, Curtis R, Goldstein M, Ildefonso G, et al. Sociometric risk networks and HIV risk. American Journal of Public Health. 1997;87(8):1289–96.CrossRefPubMedPubMedCentral

22.

Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related mechanisms may help explain long-term HIV-1-seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol. 2000;152(10):913–22. https://doi.org/10.1093/aje/152.10.913. http://aje.oxfordjournals.org/content/152/10/913.full CrossRefPubMed

23.

Gyarmathy VA, Neaigus A. The effect of personal network exposure on injecting equipment sharing among IDUs in Budapest. Hungary Connections. 2006;27(1):25–38.

24.

Weeks MR, Clair S, Borgatti SP, Radda K, Schensul JJ. Social networks of drug users in high-risk sites: finding the connections. AIDS Behav. 2002;6(2):193–206.CrossRef

25.

Yang C, Latkin C, Muth SQ, Rudolph A. Injection drug users’ involvement in drug economy: dynamics of sociometric and egocentric social networks. Connect (Tor). 2013;33(1):24–34. PMC4193503

26.

Wendel T, Khan B, Dombrowski K, et al. Dynamics of methamphetamine markets in New York City: final technical report to the National Institute of Justice (Document No: 23611). 2011.

27.

Kuhns LM, Birkett M, Muth S, et al. Methods for collection of participant-aided sociograms for the study of social, sexual and substance-using networks among young men who have sex with men. Connect. 2015;35(1)

28.

Rothenberg R, Baldwin J, Trotter R, Muth S. The risk environment for HIV transmission: results from the Atlanta and flagstaff network studies. Journal of Urban Health: Bulletin of the New York Academy of Medicine. 2001;78(3):419–32.CrossRef

29.

Rudolph AE, Latkin C, Crawford ND, Jones KC, Fuller CM. Does respondent driven sampling alter the social network composition and health-seeking behaviors of illicit drug users followed prospectively? PLoS One. 2011;6(5):e19615.CrossRefPubMedPubMedCentral

30.

Go VF, Latkin C, Le Minh N, et al. Variations in the role of social support on disclosure among newly diagnosed HIV-infected people who inject drugs in Vietnam. AIDS Behav. 2015:1–10.

31.

Go V, Frangakis C, Minh N, et al. Efficacy of a multi-level intervention to reduce injecting and sexual risk behaviors among HIV-infected people who inject drugs in Vietnam: a four-arm randomized controlled trial. PLoS One. 2014;10(5):e0125909.CrossRef

32.

Potterat JJ, Rothenberg RB, Muth SQ. Network structural dynamics and infectious disease propagation. Int J STD AIDS. 1999;10(3):182–5.CrossRefPubMed

33.

Curtis, KM, Misshula, E, Riggs, Marshall, DM, IV. Dynamics of methamphetamine markets in New York City: final technical report to the National Institute of Justice. Document # 236122. Date: October 2011. Available at http://snrg-nyc.org/wp-content/uploads/2012/07/Meth-Report.pdf

34.

Dombrowski K, Khan B, Wendel T, McLean K, Misshula E, Curtis R. Estimating the size of the methamphetamine-using population in New York City using network sampling techniques. Advances in Applied Sociology. 2012;2(4):245–52.CrossRefPubMedPubMedCentral

35.

Odell, KM, Russell, RC. Soundex phonetic comparison system [cf. U.S. Patents 1261167 (1918), 1435663 (1922)].

36.

Shannon CE. A mathematical theory of communication, part I, part II. Bell Syst Tech J. 1948;27:623–56.CrossRef

37.

Lait, AJ, Randell, B An assessment of name matching algorithm, Society of Indexers Genealogical Group, Newsletter Contents, SIGGNL issues 17, 1998.

38.

Hopkins C, Young AM. SPIDER: semi-automated processing of interconnected dyads using entity resolution [computer program]. 2017. Available at:https://www.cra.com/spider.

39.

LinkAlyzer (http://socioworks.com/productsall/linkalyzer/) [computer program]. 2001.

40.

Young AM, Rudolph AE, Havens JR. Network-based research on rural opioid use: an overview of methods and lessons learned. Current HIV/AIDS Reports. 2018; https://doi.org/10.1007/s11904-018-0391-2.

41.

Kottiri BJ, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. JAIDS. 2002;30:95–104.PubMed

42.

Dombrowski K, Khan B, Curtis R, Friedman S. Topological and historical considerations for infectious disease transmission among injecting drug users in Bushwick, Brooklyn (USA). World Journal of AIDS. 2013;3:1–9. https://doi.org/10.4236/wja.2013.31001 Published Online March 2013 (http://www.scirp.org/journal/wja).

43.

Dombrowski K, Khan B, McLean K, Curtis R, Wendel T, Misshula E, et al. A re-examination of connectivity trends via exponential random graph modeling in two IDU risk networks. Subst Use Misuse. 2013;48(14):1485–97.CrossRefPubMedPubMedCentral

44.

Dombrowski K, Khan B, Habecker P, Hagan H, Friedman SR, Saad M. The interaction of risk network structures and virus natural history in the non-spreading of HIV among people who inject drugs in the early stages of the epidemic. AIDS Behav. 2017;21(4):1004–15. https://doi.org/10.1007/s10461-016-1568-6.CrossRefPubMedPubMedCentral

45.

Khan, B, Dombrowski, K, Saad, M, Mclean, K Friedman, SR. Network firewall dynamics and the sub-saturation stabilization of HIV, Discret Dyn Nat Soc 2013; 2013(151). DOI: https://doi.org/10.1155/2013/720818, 1, 16

46.

Friedman, SR, Williams, LD, Pavlatina, E, Paraskevis D, Schneider J, Skaathun B et al. Transmission Reduction Intervention Project Collaboration Group. Networks of recently-infected people who inject drugs (PWID) in Athens, Greece, June 2013–July 2015: epidemiological insight from a project to reduce HIV transmission International AIDS Conference, Durban, 2016. TUPEC230.

47.

Friedman SR, Bolyard M, Sandoval M, Mateu-Gelabert P, Maslow C, Zenilman JM. The relative prevalence of different STIs in HIV-discordant sexual partnerships: data from a risk network study in a high-risk New York neighborhood. Sex Transm Infect. 2008;84(1):17–8.CrossRefPubMed

48.

Friedman SR, Bolyard M, Khan M, Maslow C, Sandoval M, Mateu-Gelabert P, et al. Group sex events and HIV/STI risk in an urban network. J Acq Immun Syn. 2008;49(4):440–6.CrossRef

49.

Latkin C, Yang C, Tobin K, Hulbert A. Factors associated with recruiting an HIV seropositive risk network member among injection drug users. AIDS Behav. 2010;14(5):1137–41. https://doi.org/10.1007/s10461-010-9676-1.CrossRefPubMedPubMedCentral

50.

Latkin C, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D. The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013;108(5):934–43. https://doi.org/10.1111/add.12095.CrossRefPubMedPubMedCentral

51.

Latkin CA, Kuramoto SJ, Davey-Rothwell MA, Tobin KE. Social norms, social networks, and HIV risk behavior among injection drug users. AIDS Behav. 2010;14(5):1159–68. https://doi.org/10.1007/s10461-009-9576-4.CrossRefPubMed

52.

Tobin KE, Hua W, Costenbader EC, Latkin CA. The association between change in social network characteristics and non-fatal overdose: results from the SHIELD study in Baltimore, MD, USA. Drug Alcohol Depend. 2007;87(1):63–8.CrossRefPubMed

53.

Latkin CA, Hua W, Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend. 2004;73(1):61–7.CrossRefPubMed

54.

Davey-Rothwell MA, Kuramoto SJ, Latkin CA. Social networks, norms, and 12-step group participation. Am J Drug Alcohol Abuse. 2008;34(2):185–93. https://doi.org/10.1080/00952990701877086.CrossRefPubMed

55.

Davey MA, Latkin CA, Hua W, Tobin KE, Strathdee S. Individual and social network factors that predict entry to drug treatment. Am J Addict. 2007;16(1):38–45.CrossRefPubMed

56.

Tsang MA, Schneider JA, Sypsa V, Schumm P, Nikolopoulos GK, Paraskevis D, et al. Network characteristics of people who inject drugs within a new HIV epidemic following austerity in Athens, Greece. J Acquir Immune Defic Syndr. 2015;69(4):499–508.CrossRefPubMedPubMedCentral

57.

Knowlton AR, Hua W, Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 2005;17(4):479–92.CrossRefPubMed

58.

Maragh-Bass AC, Denison JA, Thorpe RJ Jr, Knowlton AR. The interactive effects of social support and physical functioning on HIV medical outcomes among African Americans whom inject drugs. J Ethn Subst Abuse. 2017:1–19. https://doi.org/10.1080/15332640.2016.1264337.

59.

Smyrnov P, Williams LD, Korobchuk A, Sazonova Y, Nikolopoulos GK, Skaathun B, et al. Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine. J Int AIDS Soc. 2018;21(1):e25040. https://doi.org/10.1002/jia2.25040.CrossRefPubMedCentral

60.

Morgan E, Skaathun B, Nikolopoulos GK, Paraskevis D, Friedman S, Schneider JA. A network intervention to locate newly infected persons within MSM networks in Chicago. AIDS Behav; under review.

61.

Mateu-Gelabert P, Jessell L, Goodbody E, Kim D, Gile K, Teubl J, et al. High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City. International Journal on Drug Policy. 2017;46:17–27.CrossRefPubMed

62.

Friedman SR, Mateu-Gelabert P, Ruggles KV, Goodbody E, Sykes C, Jessell L, et al. Sexual risk and transmission behaviors, partnerships and settings among young adult opioid users in New York City. AIDS Behav. 2017;21(4):994–1003. https://doi.org/10.1007/s10461-016-1672-7.NIHMSID841274.CrossRefPubMedPubMedCentral

Title: Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics
Authors: Samuel R. Friedman
Leslie Williams
April M. Young
Jennifer Teubl
Dimitrios Paraskevis
Evangelia Kostaki
Carl Latkin
Danielle German
Pedro Mateu-Gelabert
Honoria Guarino
Tetyana I. Vasylyeva
Britt Skaathun
John Schneider
Ania Korobchuk
Pavlo Smyrnov
Georgios Nikolopoulos
Publication date: 01-06-2018
Publisher: Springer US
Published in: Current HIV/AIDS Reports / Issue 3/2018
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-018-0403-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2018

Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition

Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C

Continued Interest and Controversy: Vitamin D in HIV

Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk

HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers

NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage